Treatment of Recurrent Depression

 
 
American Psychiatric Association Publishing
  • erschienen am 1. Mai 2001
 
  • Buch
  • |
  • Softcover
  • |
  • 214 Seiten
978-1-58562-025-8 (ISBN)
 
Based on powerful epidemiological data such as numbers afflicted, mortality rates from suicide, personal and familial consequences, and skyrocketing fiscal costs, major depressive disorder (MDD) has the sad and ignominious distinction of being a leader among disabling disorders worldwide.

With lifetime prevalence risks of 13% for men and 21% for women, the magnitude of this crisis cannot be understated. This hard-hitting volume focuses on recurrences -- perhaps most important among the many factors (others include extreme underdiagnosis and undertreatment, genetic vulnerability, frequent recurrences, severe stigma and poor adherence with maintenance treatment, and brain tissue degenerative changes associated with recurrences and chronic depression) that contribute to MDD's high morbidity.

Following an introduction by the editor detailing the overwhelming personal and societal burden created by MDD, the distinguished authors of this volume emphasize five critical topics: The lifetime impact of gender on recurrent MDD in women, emphasizing the clinical features, treatment, and prevention strategies of the illness during three key periods of hormone transition (adolescence, childbearing years, and middle life) and including recommendations on where future research should focus. Treatment strategies for chronic and recurrent depression to help prevent acute episodes from developing into long-term depression, specifically addressing the continuing question of whether pharmacotherapy and psychotherapy combinations are superior to either alone. Prevention of recurrences in bipolar patients, updating the demonstrated benefits of several new anticonvulsant mood stabilizers and integrative treatment approaches and suggesting that treatment success depends on a multifaceted approach that combines old and new pharmacotherapy. Potential applications of new somatic treatment strategies involving minimally invasive brain stimulation that have greatly reduced the stigma but done little to advance the diagnosis and treatment of neuropsychiatric illnesses, with exciting data suggesting the efficacy of vagal nerve stimulation (VNS) and repetitive transcranial magnetic stimulation (TMS). A "call to arms" with updated recommendations on how to ensure demonstrable, lasting progress in preventing recurrences of depression, which -- along with other chronic diseases such as diabetes, heart disease, and schizophrenia -- progresses throughout life unless actively treated.

This highly informative volume, clearly written and exceptionally well referenced, is a "must-read" for every clinician, including specialists in depression and clinical neurosciences, primary care physicians and mental health clinicians interested in learning more about how to successfully treat what remains one of our most recalcitrant, debilitating illnesses.
  • Englisch
  • VA
  • |
  • USA
  • Für höhere Schule und Studium
  • |
  • Für Beruf und Forschung
  • Broschur/Paperback
  • Höhe: 229 mm
  • |
  • Breite: 150 mm
  • |
  • Dicke: 13 mm
  • 363 gr
978-1-58562-025-8 (9781585620258)
1585620254 (1585620254)

weitere Ausgaben werden ermittelt
John F. Greden, M.D., is Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences, Chair of the Department of Psychiatry, Senior Research Scientist at the Mental Health Research Institute, and Director of The University of Michigan Depression Center at The University of Michigan in Ann Arbor, Michigan.
ContributorsIntroduction to the Review of Psychiatry SeriesChapter 1. Recurrent depression and its overwhelming burdenChapter 2. Recurrent depression in women throughout the life spanChapter 3. Chronic and recurrent depression: Pharmacotherapy and psychotherapy combinationsChapter 4. Prevention of recurrences in patients with bipolar disorder: The best of the old and the newChapter 5. New depression treatment strategies: What does the future hold for therapeutic uses of minimally invasive brain stimulation?Chapter 6. Clinical prevention of recurrent depression: The need for paradigm shiftsIndex
"This is the most complete and organized presentation I have ever seen for identification and acute and maintenance treatment of recurrent major depression."-- "Barbara Gambill Sanders, M.S., M.S.W., Psychiatric Services", "April 2003" "This concise and clear presentation provides easy to understand statistical information about prevalence and types of treatment of recurrent depression."-- "Doody Health Science Review", "September 2001"

Versand in 3-4 Wochen

59,79 €
inkl. 7% MwSt.
in den Warenkorb

Abholung vor Ort? Sehr gerne!
Unsere Web-Seiten verwenden Cookies. Mit der Nutzung des WebShops erklären Sie sich damit einverstanden. Mehr Informationen finden Sie in unserem Datenschutzhinweis. Ok